SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.88+0.2%Nov 25 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert K. who wrote (16856)5/14/2004 11:19:22 AM
From: Bluegreen   of 17367
 
Bob, WHAT IF RAPTIVA DOESN'T GET EUROPEAN APPROVAL????? What will the stock price be IF RAPTIVA DOESN'T GET EUROPEAN APPROVAL???? What IF Raptiva sales are anemic here in the USA?????? WHY did Baxter dump Neuprex????? WHY isn't Neuprex talked about as much as it was????? HOW MUCH is the acne stuff going to COST IF it gets to market and what about possible COMPETITION from MICROLOGIX????? WHAT if CHIRON BACKS out on XOMA like Baxter did not long ago?????? Does 4 dollars look like a GOOD exit point considering ALL THE RISKS in this STOCK???? And before I forget to thank SCANNON for the epiphany...........THANK YOU SCANNON FOR SHOWING THE WAY ON FLIPPING ALL THOSE OPTIONS........IT WAS A GREAT MESSAGE TO SEND TO SHAREHOLDERS(OOPS, OR SHOULD I SAY BAGHOLDERS????)LOL!!!!!!!!!!!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext